Jiawen Feng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jiawen Feng has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Yuxin Yin
Department of Biomedical Sciences, Division of Biomedical Health Sciences, School of Medicine, The Chinese University of Hong Kong, Shenzhen, China
4 shared publications - Ling Liang
Peking University, Beijing, China
3 shared publications Ao Yang
Department of Biophysics School of Basic Medical Sciences, Peking University Health Science Center Beijing China
2 shared publicationsShang Yu
Department of Biophysics School of Basic Medical Sciences, Peking University Health Science Center Beijing China
2 shared publications- Zonglin Dai
Institute of Systems Biomedicine, Department of Pathology, Beijing Key Laboratory of Tumor Systems Biology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China
2 shared publications Chuanda Zhu
Department of Biophysics School of Basic Medical Sciences, Peking University Health Science Center Beijing China
1 shared publication
Latest Publications
- 9 November 2026
- Published by Wiley in Protein Science
- Vol. 35 (12)
Cryo‐ EM reveals an autoinhibited dimeric state of the neddylated CRL2 FEM1B E3 ubiquitin ligase
Cullin–RING E3 ubiquitin ligases (CRLs) constitute the largest family of E3 ligases in eukaryotes and are estimated to mediate the ubiquitylation of approximately 20% of proteins degraded through the ubiquitin–proteasome system. CRL activity is generally stimulated by covalent modification of the cullin scaffold with NEDD8. Here, using cryo‐electron microscopy combined with biochemical and cellular ubiquitylation assays, we characterize an autoinhibited state of neddylated CRL2 FEM1B . Structures of N8‐CRL2 FEM1B in the absence and presence of the FNIP1 degron reveal a crown‐shaped homodimer stabilized by interprotomer CUL2–RBX1 contacts. Although this dimer retains an accessible substrate‐binding site and efficiently engages the FNIP1 degron , its catalytic module is constrained, limiting productive E2–ubiquitin engagement and substrate ubiquitylation. Disruption of the CUL2–RBX1 dimer interface markedly enhances FNIP1 degron ubiquitylation both in vitro and in cells. Together, these findings identify an autoinhibited state of N8‐CRL2 FEM1B that efficiently recognizes the isolated FNIP1 degron but has limited activity towards this substrate. They support a model in which substrate‐dependent remodeling or dissociation of this dimer enables efficient ubiquitylation, revealing an additional layer of CRL2 FEM1B regulation after neddylation.
- 9 November 2026
- Published by Wiley in Protein Science
- Vol. 35 (12)
Cryo‐ EM reveals an autoinhibited dimeric state of the neddylated CRL2 FEM1B E3 ubiquitin ligase
Cullin–RING E3 ubiquitin ligases (CRLs) constitute the largest family of E3 ligases in eukaryotes and are estimated to mediate the ubiquitylation of approximately 20% of proteins degraded through the ubiquitin–proteasome system. CRL activity is generally stimulated by covalent modification of the cullin scaffold with NEDD8. Here, using cryo‐electron microscopy combined with biochemical and cellular ubiquitylation assays, we characterize an autoinhibited state of neddylated CRL2 FEM1B . Structures of N8‐CRL2 FEM1B in the absence and presence of the FNIP1 degron reveal a crown‐shaped homodimer stabilized by interprotomer CUL2–RBX1 contacts. Although this dimer retains an accessible substrate‐binding site and efficiently engages the FNIP1 degron , its catalytic module is constrained, limiting productive E2–ubiquitin engagement and substrate ubiquitylation. Disruption of the CUL2–RBX1 dimer interface markedly enhances FNIP1 degron ubiquitylation both in vitro and in cells. Together, these findings identify an autoinhibited state of N8‐CRL2 FEM1B that efficiently recognizes the isolated FNIP1 degron but has limited activity towards this substrate. They support a model in which substrate‐dependent remodeling or dissociation of this dimer enables efficient ubiquitylation, revealing an additional layer of CRL2 FEM1B regulation after neddylation.
- Open Access
- 23 September 2026
- Published by Elsevier in Cell Press Blue
- Vol. 1 (8)
Architecture of the human KICSTOR complex and its role in mTORC1 regulation
- 23 September 2026
- Published by Elsevier in Cell Press Blue
- Vol. 1 (8)
Open AccessArchitecture of the human KICSTOR complex and its role in mTORC1 regulation
- 1 July 2026
- Published by American Association for Cancer Research (AACR) in Cancer Discovery
- Vol. 16 (7) , 1258-1261
Reconsidering Cancer Therapy through the Lens of Biomolecular Condensates
Summary: Biomolecular condensates formed via phase separation are emerging targets for pharmacologic or genetic manipulation for cancer therapy. In this commentary, we envisage that further deciphering the composition and the physicochemical properties of oncogenic condensates will provide unprecedented opportunities to develop novel strategies for cancer chemotherapy and immunotherapy.
- 1 July 2026
- Published by American Association for Cancer Research (AACR) in Cancer Discovery
- Vol. 16 (7) , 1258-1261
Reconsidering Cancer Therapy through the Lens of Biomolecular Condensates
Summary: Biomolecular condensates formed via phase separation are emerging targets for pharmacologic or genetic manipulation for cancer therapy. In this commentary, we envisage that further deciphering the composition and the physicochemical properties of oncogenic condensates will provide unprecedented opportunities to develop novel strategies for cancer chemotherapy and immunotherapy.
- 17 March 2025
- Published by Wiley in The FASEB Journal
- Vol. 39 (6) , e70419
ZUP1 is a key component of the MAVS complex and acts as a protector of host against viral invasion
Zinc finger‐containing ubiquitin peptidase 1 (ZUP1) is a protein characterized by four N‐terminal zinc finger domains and a C‐terminal deubiquitinase (DUB) domain. While it is associated with the DNA damage response, the role of ZUP1 in innate immunity remains unclear. Here, we identify ZUP1 as a crucial component of the mitochondrial antiviral signaling (MAVS) complex, essential for host antiviral defense. We show that viral infection significantly upregulates ZUP1 expression, and mice lacking ZUP1 exhibit impaired type I interferon (IFN) production and increased susceptibility to viral infection, as evidenced by higher mortality rates. This underscores the protective role of ZUP1 in host immunity. Mechanistically, ZUP1 binds to MAVS through its C‐terminal domain independently of DUB activity. Instead, ZUP1 utilizes its zinc finger domains, particularly the third zinc finger, to directly bind viral RNA. This interaction enhances the association of ZUP1 with MAVS and promotes its aggregation on mitochondria during viral infection. ZUP1 also interacts with TBK1 and NEMO within the MAVS complex, facilitating IRF3 activation and type I IFN production. These findings establish ZUP1 as a zinc finger‐containing regulator that amplifies MAVS‐dependent antiviral immunity, linking viral RNA recognition to downstream signaling and highlighting potential targets for therapeutic intervention against viral infections.
- 17 March 2025
- Published by Wiley in The FASEB Journal
- Vol. 39 (6) , e70419
ZUP1 is a key component of the MAVS complex and acts as a protector of host against viral invasion
Zinc finger‐containing ubiquitin peptidase 1 (ZUP1) is a protein characterized by four N‐terminal zinc finger domains and a C‐terminal deubiquitinase (DUB) domain. While it is associated with the DNA damage response, the role of ZUP1 in innate immunity remains unclear. Here, we identify ZUP1 as a crucial component of the mitochondrial antiviral signaling (MAVS) complex, essential for host antiviral defense. We show that viral infection significantly upregulates ZUP1 expression, and mice lacking ZUP1 exhibit impaired type I interferon (IFN) production and increased susceptibility to viral infection, as evidenced by higher mortality rates. This underscores the protective role of ZUP1 in host immunity. Mechanistically, ZUP1 binds to MAVS through its C‐terminal domain independently of DUB activity. Instead, ZUP1 utilizes its zinc finger domains, particularly the third zinc finger, to directly bind viral RNA. This interaction enhances the association of ZUP1 with MAVS and promotes its aggregation on mitochondria during viral infection. ZUP1 also interacts with TBK1 and NEMO within the MAVS complex, facilitating IRF3 activation and type I IFN production. These findings establish ZUP1 as a zinc finger‐containing regulator that amplifies MAVS‐dependent antiviral immunity, linking viral RNA recognition to downstream signaling and highlighting potential targets for therapeutic intervention against viral infections.
- 1 November 2024
- Published by American Association for Cancer Research (AACR) in Cancer Discovery
- Vol. 14 (11) , 2041-2046
Building an Organ-Wide Macroscopic View of Cancer Hallmarks
Summary: Despite an increasingly detailed understanding of cancer hallmarks at molecular or atomic resolution, most studies, however, fall short of investigating the systemic interactions of cancer with the human body. We propose to investigate the hallmarks of cancer from an organ-wide macroscopic view, discuss the challenges in preclinical and clinical research to study the cross-organ regulation of cancer together with potential directions to overcome these challenges, and foresee how this holistic view may be translated into more effective therapies.
- 1 November 2024
- Published by American Association for Cancer Research (AACR) in Cancer Discovery
- Vol. 14 (11) , 2041-2046
Building an Organ-Wide Macroscopic View of Cancer Hallmarks
Summary: Despite an increasingly detailed understanding of cancer hallmarks at molecular or atomic resolution, most studies, however, fall short of investigating the systemic interactions of cancer with the human body. We propose to investigate the hallmarks of cancer from an organ-wide macroscopic view, discuss the challenges in preclinical and clinical research to study the cross-organ regulation of cancer together with potential directions to overcome these challenges, and foresee how this holistic view may be translated into more effective therapies.
- 1 November 2024
- Published by American Association for Cancer Research (AACR) in Cancer Discovery
- Vol. 14 (11) , 2061-2065
Targeting Noncoding cis -Regulatory Elements for Cancer Therapy in the Context of the 3D Genome
Summary: Significant efforts have been made to identify and validate oncoproteins and ncRNAs as therapeutic targets for cancer therapy; however, emerging observations suggest that noncoding cis-regulatory elements, which orchestrate the 3D organization of the genome and thus the transcriptional landscape, are potential therapeutic targets as well. In this commentary, we envisage that further efforts to decipher the noncoding cis-regulatory code and performing systematic surveys of functional noncoding cis-regulatory elements and recurrent 3D genome alterations in both cancerous and nonmalignant cells within tumor tissues will pave the way to the development of novel therapeutic strategies.
- 1 November 2024
- Published by American Association for Cancer Research (AACR) in Cancer Discovery
- Vol. 14 (11) , 2061-2065
Targeting Noncoding cis -Regulatory Elements for Cancer Therapy in the Context of the 3D Genome
Summary: Significant efforts have been made to identify and validate oncoproteins and ncRNAs as therapeutic targets for cancer therapy; however, emerging observations suggest that noncoding cis-regulatory elements, which orchestrate the 3D organization of the genome and thus the transcriptional landscape, are potential therapeutic targets as well. In this commentary, we envisage that further efforts to decipher the noncoding cis-regulatory code and performing systematic surveys of functional noncoding cis-regulatory elements and recurrent 3D genome alterations in both cancerous and nonmalignant cells within tumor tissues will pave the way to the development of novel therapeutic strategies.
- 5 January 2024
- Published by Elsevier in Journal of Genetics and Genomics
- Vol. 51 (5) , 531-542
CircPTEN-MT from PTEN regulates mitochondrial energy metabolism
- 5 January 2024
- Published by Elsevier in Journal of Genetics and Genomics
- Vol. 51 (5) , 531-542
CircPTEN-MT from PTEN regulates mitochondrial energy metabolism
- Open Access
- 24 April 2020
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-15
Molecular basis for assembly of the shieldin complex and its implications for NHEJ
Shieldin, including SHLD1, SHLD2, SHLD3 and REV7, functions as a bridge linking 53BP1-RIF1 and single-strand DNA to suppress the DNA termini nucleolytic resection during non-homologous end joining (NHEJ). However, the mechanism of shieldin assembly remains unclear. Here we present the crystal structure of the SHLD3-REV7-SHLD2 ternary complex and reveal an unexpected C (closed)-REV7-O (open)-REV7 conformational dimer mediated by SHLD3. We show that SHLD2 interacts with O-REV7 and the N-terminus of SHLD3 by forming β sheet sandwich. Disruption of the REV7 conformational dimer abolishes the assembly of shieldin and impairs NHEJ efficiency. The conserved FXPWFP motif of SHLD3 binds to C-REV7 and blocks its binding to REV1, which excludes shieldin from the REV1/Pol ζ translesion synthesis (TLS) complex. Our study reveals the molecular architecture of shieldin assembly, elucidates the structural basis of the REV7 conformational dimer, and provides mechanistic insight into orchestration between TLS and NHEJ.
- 24 April 2020
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-15
Open AccessMolecular basis for assembly of the shieldin complex and its implications for NHEJ
Shieldin, including SHLD1, SHLD2, SHLD3 and REV7, functions as a bridge linking 53BP1-RIF1 and single-strand DNA to suppress the DNA termini nucleolytic resection during non-homologous end joining (NHEJ). However, the mechanism of shieldin assembly remains unclear. Here we present the crystal structure of the SHLD3-REV7-SHLD2 ternary complex and reveal an unexpected C (closed)-REV7-O (open)-REV7 conformational dimer mediated by SHLD3. We show that SHLD2 interacts with O-REV7 and the N-terminus of SHLD3 by forming β sheet sandwich. Disruption of the REV7 conformational dimer abolishes the assembly of shieldin and impairs NHEJ efficiency. The conserved FXPWFP motif of SHLD3 binds to C-REV7 and blocks its binding to REV1, which excludes shieldin from the REV1/Pol ζ translesion synthesis (TLS) complex. Our study reveals the molecular architecture of shieldin assembly, elucidates the structural basis of the REV7 conformational dimer, and provides mechanistic insight into orchestration between TLS and NHEJ.